Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury.

Jong Woong Park, Kwang Mo Kim, Kwang Joon Oh, Im Joo Rhyu, Hyon Seok Jang

Research output: Contribution to journalArticle

Abstract

BACKGROUNDS: The proteasome degrades NF-kappaB blocking protein (I-kappaB) and activates NF-kappaB that plays as a key transcriptional factor to regulate inflammatory factors that are involved in the tissue reperfusion injury. This study was designed to assess whether the proteasome inhibitor can attenuate peripheral nerve ischemia/reperfusion (I/R) injury and consequently promote motor functional recovery after ischemic insult. METHODS: Rat sciatic nerves were exposed to 2 hour of ischemia followed by various periods of reperfusion. Rats were administered either proteasome inhibitor (bortezomib) or phosphate-buffered saline 30 minutes before reperfusion start. Results were evaluated using a walking track test, and an isolated muscle contraction test, and by muscle weight, and histology. RESULTS: Bortezomib treatment induced an earlier improvement in sciatic functional index and a more rapid restoration of contractile force and wet weight of extensor digitorum longus muscle. Bortezomib reduced early axonal degeneration and promoted regeneration. CONCLUSION: This study indicates that bortezomib; a proteasome inhibitor, is effective at promoting the functional recovery of reperfused peripheral nerve. The proteasome inhibition may play a role as one of the clinical strategy in the peripheral nervous system I/R injury with further understanding its mechanism of action.

Original languageEnglish
Pages (from-to)743-748
Number of pages6
JournalThe Journal of trauma
Volume66
Issue number3
Publication statusPublished - 2009 Mar 1

Fingerprint

Peripheral Nerve Injuries
Proteasome Endopeptidase Complex
Reperfusion Injury
Proteasome Inhibitors
NF-kappa B
Peripheral Nerves
Reperfusion
Weights and Measures
Muscles
Peripheral Nervous System
Sciatic Nerve
Muscle Contraction
Walking
Regeneration
Histology
Ischemia
Phosphates
Bortezomib
Proteins
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury. / Park, Jong Woong; Kim, Kwang Mo; Oh, Kwang Joon; Rhyu, Im Joo; Jang, Hyon Seok.

In: The Journal of trauma, Vol. 66, No. 3, 01.03.2009, p. 743-748.

Research output: Contribution to journalArticle

@article{e4aae461b93645d7a40ff2eac05ed883,
title = "Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury.",
abstract = "BACKGROUNDS: The proteasome degrades NF-kappaB blocking protein (I-kappaB) and activates NF-kappaB that plays as a key transcriptional factor to regulate inflammatory factors that are involved in the tissue reperfusion injury. This study was designed to assess whether the proteasome inhibitor can attenuate peripheral nerve ischemia/reperfusion (I/R) injury and consequently promote motor functional recovery after ischemic insult. METHODS: Rat sciatic nerves were exposed to 2 hour of ischemia followed by various periods of reperfusion. Rats were administered either proteasome inhibitor (bortezomib) or phosphate-buffered saline 30 minutes before reperfusion start. Results were evaluated using a walking track test, and an isolated muscle contraction test, and by muscle weight, and histology. RESULTS: Bortezomib treatment induced an earlier improvement in sciatic functional index and a more rapid restoration of contractile force and wet weight of extensor digitorum longus muscle. Bortezomib reduced early axonal degeneration and promoted regeneration. CONCLUSION: This study indicates that bortezomib; a proteasome inhibitor, is effective at promoting the functional recovery of reperfused peripheral nerve. The proteasome inhibition may play a role as one of the clinical strategy in the peripheral nervous system I/R injury with further understanding its mechanism of action.",
author = "Park, {Jong Woong} and Kim, {Kwang Mo} and Oh, {Kwang Joon} and Rhyu, {Im Joo} and Jang, {Hyon Seok}",
year = "2009",
month = "3",
day = "1",
language = "English",
volume = "66",
pages = "743--748",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury.

AU - Park, Jong Woong

AU - Kim, Kwang Mo

AU - Oh, Kwang Joon

AU - Rhyu, Im Joo

AU - Jang, Hyon Seok

PY - 2009/3/1

Y1 - 2009/3/1

N2 - BACKGROUNDS: The proteasome degrades NF-kappaB blocking protein (I-kappaB) and activates NF-kappaB that plays as a key transcriptional factor to regulate inflammatory factors that are involved in the tissue reperfusion injury. This study was designed to assess whether the proteasome inhibitor can attenuate peripheral nerve ischemia/reperfusion (I/R) injury and consequently promote motor functional recovery after ischemic insult. METHODS: Rat sciatic nerves were exposed to 2 hour of ischemia followed by various periods of reperfusion. Rats were administered either proteasome inhibitor (bortezomib) or phosphate-buffered saline 30 minutes before reperfusion start. Results were evaluated using a walking track test, and an isolated muscle contraction test, and by muscle weight, and histology. RESULTS: Bortezomib treatment induced an earlier improvement in sciatic functional index and a more rapid restoration of contractile force and wet weight of extensor digitorum longus muscle. Bortezomib reduced early axonal degeneration and promoted regeneration. CONCLUSION: This study indicates that bortezomib; a proteasome inhibitor, is effective at promoting the functional recovery of reperfused peripheral nerve. The proteasome inhibition may play a role as one of the clinical strategy in the peripheral nervous system I/R injury with further understanding its mechanism of action.

AB - BACKGROUNDS: The proteasome degrades NF-kappaB blocking protein (I-kappaB) and activates NF-kappaB that plays as a key transcriptional factor to regulate inflammatory factors that are involved in the tissue reperfusion injury. This study was designed to assess whether the proteasome inhibitor can attenuate peripheral nerve ischemia/reperfusion (I/R) injury and consequently promote motor functional recovery after ischemic insult. METHODS: Rat sciatic nerves were exposed to 2 hour of ischemia followed by various periods of reperfusion. Rats were administered either proteasome inhibitor (bortezomib) or phosphate-buffered saline 30 minutes before reperfusion start. Results were evaluated using a walking track test, and an isolated muscle contraction test, and by muscle weight, and histology. RESULTS: Bortezomib treatment induced an earlier improvement in sciatic functional index and a more rapid restoration of contractile force and wet weight of extensor digitorum longus muscle. Bortezomib reduced early axonal degeneration and promoted regeneration. CONCLUSION: This study indicates that bortezomib; a proteasome inhibitor, is effective at promoting the functional recovery of reperfused peripheral nerve. The proteasome inhibition may play a role as one of the clinical strategy in the peripheral nervous system I/R injury with further understanding its mechanism of action.

UR - http://www.scopus.com/inward/record.url?scp=63149093641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63149093641&partnerID=8YFLogxK

M3 - Article

C2 - 19276748

VL - 66

SP - 743

EP - 748

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 3

ER -